Patents by Inventor Horng-Chaung Hsu

Horng-Chaung Hsu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9662350
    Abstract: A pharmaceutical composition for inhibiting inflammation is provided. The pharmaceutical composition comprises (a) hyaluronic acid, (b) a vitamin and (c) a pharmaceutically acceptable carrier.
    Type: Grant
    Filed: August 6, 2014
    Date of Patent: May 30, 2017
    Assignee: CHINA MEDICAL UNIVERSITY
    Inventors: Feng-Huei Lin, Teng-Le Huang, Horng-Chaung Hsu, Chun-Hsu Yao, Yueh-Sheng Chen, Wen-Yu Su
  • Publication number: 20150094279
    Abstract: A pharmaceutical composition for inhibiting inflammation is provided. The pharmaceutical composition comprises (a) hyaluronic acid, (b) a vitamin and (c) a pharmaceutically acceptable carrier.
    Type: Application
    Filed: August 6, 2014
    Publication date: April 2, 2015
    Inventors: Feng-Huei LIN, Teng-Le HUANG, Horng-Chaung HSU, Chun-Hsu YAO, Yueh-Sheng CHEN, Wen-Yu SU
  • Patent number: 8835405
    Abstract: A pharmaceutical composition for inhibiting inflammation is provided. The pharmaceutical composition comprises (a) hyaluronic acid, (b) a vitamin and (c) a pharmaceutically acceptable carrier.
    Type: Grant
    Filed: December 23, 2011
    Date of Patent: September 16, 2014
    Assignee: China Medical University
    Inventors: Feng-Huei Lin, Teng-Le Huang, Horng-Chaung Hsu, Chun-Hsu Yao, Yueh-Sheng Chen, Wen-Yu Su
  • Patent number: 8691796
    Abstract: A pharmaceutical composition for inhibiting inflammation, comprising (a) hyaluronic acid, (b) a 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitor, and (c) a pharmaceutically acceptable carrier, is provided. Also provided is a method for inhibiting inflammation in a mammal, comprising administrating to the mammal an effective amount of a composition comprising (a) hyaluronic acid and (b) an HMG-CoA reductase inhibitor.
    Type: Grant
    Filed: February 10, 2011
    Date of Patent: April 8, 2014
    Assignee: China Medical University
    Inventors: Feng-Huei Lin, Teng-Le Huang, Horng-Chaung Hsu
  • Publication number: 20130072452
    Abstract: A pharmaceutical composition for inhibiting inflammation is provided. The pharmaceutical composition comprises (a) hyaluronic acid, (b) a vitamin and (c) a pharmaceutically acceptable carrier.
    Type: Application
    Filed: December 23, 2011
    Publication date: March 21, 2013
    Applicant: CHINA MEDICAL UNIVERSITY
    Inventors: Feng-Huei LIN, Teng-Le HUANG, Horng-Chaung HSU, Chun-Hsu YAO, Yueh-Sheng CHEN, Wen-Yu SU
  • Publication number: 20120108536
    Abstract: A pharmaceutical composition for inhibiting inflammation, comprising (a) hyaluronic acid, (b) a 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitor, and (c) a pharmaceutically acceptable carrier, is provided. Also provided is a method for inhibiting inflammation in a mammal, comprising administrating to the mammal an effective amount of a composition comprising (a) hyaluronic acid and (b) an HMG-CoA reductase inhibitor.
    Type: Application
    Filed: February 10, 2011
    Publication date: May 3, 2012
    Applicant: CHINA MEDICAL UNIVERSITY
    Inventors: Feng-Huei Lin, Teng-Le Huang, Horng-Chaung Hsu